|
1
|
Li C, Miao R, Liu S, Wan Y, Zhang S, Deng
Y, Bi J, Qu K, Zhang J and Liu C: Down-regulation of miR-146b-5p by
long noncoding RNA MALAT1 in hepatocellular carcinoma promotes
cancer growth and metastasis. Oncotarget. 8:28683–28695.
2017.PubMed/NCBI
|
|
2
|
Lu PH, Chen MB, Liu YY, Wu MH, Li WT, Wei
MX, Liu CY and Qin SK: Identification of sphingosine kinase 1
(SphK1) as a primary target of icaritin in hepatocellular carcinoma
cells. Oncotarget. 8:22800–22810. 2017.PubMed/NCBI
|
|
3
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trépo C, Chan HL and Lok A: Hepatitis B
virus infection. Lancet. 384:2053–2063. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia
W, Ma F, Huang W, Yu L, Yue W, et al: Genome-wide association study
identifies 1p36.22 as a new susceptibility locus for hepatocellular
carcinoma in chronic hepatitis B virus carriers. Nat Genet.
42:755–758. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bréchot C: Pathogenesis of hepatitis B
virus-related hepatocellular carcinoma: Old and new paradigms.
Gastroenterology. 127 5 Suppl 1:S56–S61. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y, Qi Y, Luo J, Yang J, Xie Q, Deng C,
Su N, Wei W, Shi D, Xu F, et al: Hepatitis B virus X protein
stimulates proliferation, wound closure and inhibits apoptosis of
HuH-7 cells via CDC42. Int J Mol Sci. 18:E5862017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moriguchi M, Takayama T, Higaki T, Kimura
Y, Yamazaki S, Nakayama H, Ohkubo T and Aramaki O: Early
cancer-related death after resection of hepatocellular carcinoma.
Surgery. 151:232–237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fairman J, Liu KH and Menne S: Prevention
of liver tumor formation in woodchucks with established
hepatocellular carcinoma by treatment with cationic liposome-DNA
complexes. BMC Cancer. 17:1722017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie X, Pan J, Wei L, Wu S, Hou H, Li X and
Chen W: Gene expression profiling of microRNAs associated with UCA1
in bladder cancer cells. Int J Oncol. 48:1617–1627. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun XJ, Wang Q, Guo B, Liu XY and Wang B:
Identification of skin-related lncRNAs as potential biomarkers that
involved in Wnt pathways in keloids. Oncotarget. 8:34236–34244.
2017.PubMed/NCBI
|
|
14
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: LncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao C, Sun J, Zhang D, Guo X, Xie L, Li X,
Wu D and Liu L: The long intergenic noncoding RNA UFC1, a target of
MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to
increase levels of β-catenin in HCC cells. Gastroenterology.
148:415–426.e18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou M, Zhang XY and Yu X: Overexpression
of the long non-coding RNA SPRY4-IT1 promotes tumor cell
proliferation and invasion by activating EZH2 in hepatocellular
carcinoma. Biomed Pharmacother. 85:348–354. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Colombo T, Farina L, Macino G and Paci P:
PVT1: A rising star among oncogenic long noncoding RNAs. Biomed Res
Int. 2015:3042082015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu J, Han J, Zhang J, Li G, Liu H, Cui X,
Xu Y, Li T, Liu J and Wang C: The long noncoding RNAs PVT1 and
uc002mbe.2 in sera provide a new supplementary method for
hepatocellular carcinoma diagnosis. Medicine. 95:e44362016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding C, Yang Z, Lv Z, DU C, Xiao H, Peng
C, Cheng S, Xie H, Zhou L, Wu J and Zheng S: Long non-coding RNA
PVT1 is associated with tumor progression and predicts recurrence
in hepatocellular carcinoma patients. Oncol Lett. 9:955–963. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu L, Yang N, Chen J, Zeng T, Yan S, Liu
Y, Yu G, Chen Q, Du G, Pan W, et al: LINC00052 upregulates EPB41L3
to inhibit migration and invasion of hepatocellular carcinoma by
binding miR-452-5p. Oncotarget. 8:63724–63737. 2017.PubMed/NCBI
|
|
23
|
Xu X, Wang X, Fu B, Meng L and Lang B:
Differentially expressed genes and microRNAs in bladder carcinoma
cell line 5637 and T24 detected by RNA sequencing. Int J Clin Exp
Pathol. 8:12678–12687. 2015.PubMed/NCBI
|
|
24
|
Subramanian Y, Kaliyappan K and
Ramakrishnan KS: Facile hydrothermal synthesis and characterization
of Co2GeO4/r-GO@C ternary nanocomposite as
negative electrode for Li-ion batteries. J Colloid Interface Sci.
498:76–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei L, Murphy BL, Wu G, Parker M, Easton
J, Gilbertson RJ, Zhang J and Roussel MF: Exome sequencing analysis
of murine medulloblastoma models identifies WDR11 as a potential
tumor suppressor in Group 3 tumors. Oncotarget. 8:64685–64697.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen F, Shen C, Wang X, Wang H, Liu Y, Yu
C, Lv J, He J and Wen Z: Identification of genes and pathways in
nasopharyngeal carcinoma by bioinformatics analysis. Oncotarget.
8:63738–63749. 2017.PubMed/NCBI
|
|
27
|
Bornstein S, Schmidt M, Choonoo G, Levin
T, Gray J, Thomas CR Jr, Wong M and McWeeney S: IL-10 and integrin
signaling pathways are associated with head and neck cancer
progression. BMC Genomics. 17:382016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng JH, Xiong DD, Pang YY, Zhang Y, Tang
RX, Luo DZ and Chen G: Identification of molecular targets for
esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data
from The Cancer Genome Atlas: A study of 187 cases. Oncotarget.
8:35681–35699. 2017.PubMed/NCBI
|
|
29
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ge QM, Huang CM, Zhu XY, Bian F and Pan
SM: Differentially expressed miRNAs in sepsis-induced acute kidney
injury target oxidative stress and mitochondrial dysfunction
pathways. PLoS One. 12:e01732922017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qian Y, Feng L, Wu W, Weng T, Hu C, Hong
B, Wang FX, Shen L, Wang Q, Jin X, et al: MicroRNA expression
profiling of pancreatic cancer cell line L3.6p1 following B7-H4
knockdown. Cell Physiol Biochem. 44:494–504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong DD, Feng ZB, Cen WL, Zeng JJ, Liang
L, Tang RX, Gan XN, Liang HW, Li ZY, Chen G, et al: The clinical
value of lncRNA NEAT1 in digestive system malignancies: A
comprehensive investigation based on 57 microarray and RNA-seq
datasets. Oncotarget. 8:17665–17683. 2017.PubMed/NCBI
|
|
37
|
Chen Y, Xie H, Gao Q, Zhan H, Xiao H, Zou
Y, Zhang F, Liu Y and Li J: Colon cancer associated transcripts in
human cancers. Biomed Pharmacother. 94:531–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Z, Liu T, Wang K, Qu X, Pang Z, Liu
S, Liu Q and Du J: Down-regulation of long non-coding RNA MEG3
indicates an unfavorable prognosis in non-small cell lung cancer:
Evidence from the GEO database. Gene. 630:49–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao R, Zhang R, Zhang C, Zhao L and Zhang
Y: Long noncoding RNA CCAT1 promotes cell proliferation and
metastasis in human medulloblastoma via MAPK pathway. Tumori 0.
2017.doi: 10.5301/tj.5000662.
|
|
40
|
Jin L, Fu H, Quan J, Pan X, He T, Hu J, Li
Y, Li H, Yang Y, Ye J, et al: Overexpression of long non-coding RNA
differentiation antagonizing non-protein coding RNA inhibits the
proliferation, migration and invasion and promotes apoptosis of
renal cell carcinoma. Mol Med Rep. 16:4463–4468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu MD, Wang Y, Weng W, Wei P, Qi P, Zhang
Q, Tan C, Ni SJ, Dong L, Yang Y, et al: A positive feedback loop of
lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and
invasion. Clin Cancer Res. 23:2071–2080. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen W, Zhu H, Yin L, Wang T, Wu J, Xu J,
Tao H, Liu J and He X: lncRNA-PVT1 facilitates invasion through
upregulation of MMP9 in nonsmall cell lung cancer cell. DNA Cell
Biol. 36:787–793. 2017.PubMed/NCBI
|
|
43
|
Liu HT, Fang L, Cheng YX and Sun Q: LncRNA
PVT1 regulates prostate cancer cell growth by inducing the
methylation of miR-146a. Cancer Med. 5:3512–3519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zeng J, Liu X, Li X, Zheng Y, Liu B and
Xiao Y: Daucosterol inhibits the proliferation, migration, and
invasion of hepatocellular carcinoma cells via Wnt/β-catenin
signaling. Molecules. 22:E8622017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang J, Lai W, Li Q, Yu Y, Jin J, Guo W,
Zhou X, Liu X and Wang Y: A novel oncolytic adenovirus targeting
Wnt signaling effectively inhibits cancer-stem like cell growth via
metastasis, apoptosis and autophagy in HCC models. Biochem Biophys
Res Commun. 491:469–477. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ou W, Lv J, Zou X, Yao Y, Wu J, Yang J,
Wang Z and Ma Y: Propofol inhibits hepatocellular carcinoma growth
and invasion through the HMGA2-mediated Wnt/beta-catenin pathway.
Exp Ther Med. 13:2501–2506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng W and Fan H: Long noncoding RNA CCHE1
indicates a poor prognosis of hepatocellular carcinoma and promotes
carcinogenesis via activation of the ERK/MAPK pathway. Biomed
Pharmacother. 83:450–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin W, Zhong M, Yin H, Chen Y, Cao Q, Wang
C and Ling C: Emodin induces hepatocellular carcinoma cell
apoptosis through MAPK and PI3K/AKT signaling pathways in
vitro and in vivo. Oncol Rep. 36:961–967. 2016.
View Article : Google Scholar : PubMed/NCBI
|
